Antimicrobial Activity of Natural Products and Plants
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Plant-Derived Antibiotics".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 34758
Special Issue Editor
Special Issue Information
Dear Colleagues,
Multidrug resistance has become a huge challenge for healthcare worldwide and remains one of the leading causes of human mortality over the past few years. Bacteria, fungi, parasites, and viruses have consecutively been developing numerous resistant mechanisms against current antibiotics, hampering the success of anti-infectious therapies, and thus leading to severe consequences for patients’ health. In addition, the use of synthetic chemicals to control microorganisms is still limited due to their carcinogenic effects, acute toxicity, and environmental hazards. Hence, there is an urgent demand for new antibiotics from the scientific community to address multidrug resistance. Therapeutic agents from herbal medicines have long emerged as a potential natural source for treating infectious diseases. Today, many of these compounds have not only been rediscovered but are also the subject of new applications, nanoparticles, activity against microbial biofilms and effects on genomics, and have been discovered for new antifungal or antiviral properties.
Dr. Edyta Makuch
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new natural antimicrobial compounds and their antimicrobial effects
- clinical applications
- animal production and food storage applications
- antifungal properties
- antiviral properties
- antimicrobial mechanisms
- combination with other antimicrobials
- effects and possible global changes of the human microbiome
- new formulations based on essential oils with clinical applications for use in infectious diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.